Cargando…

CCAAT/Enhancer Binding Protein β Controls Androgen Deprivation-Induced Senescence in Prostate Cancer Cells

The processes associated with transition to castration independent prostate cancer growth are not well understood. Cellular senescence is a stable cell cycle arrest that occurs in response to sublethal stress. It is often overcome in malignant transformation to confer a survival advantage. CCAAT/Enh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barakat, David J., Zhang, Jing, Barberi, Theresa, Denmeade, Samuel R., Friedman, Alan D., Paz-Priel, Ido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573387/ https://www.ncbi.nlm.nih.gov/pubmed/25772238 http://dx.doi.org/10.1038/onc.2015.41

Ejemplares similares

Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells
por: Burton, Dominick G. A., et al.
Publicado: (2013)

Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer
por: Marshall, Catherine H., et al.
Publicado: (2021)

Regulation of Id2 expression by CCAAT/enhancer binding protein β
por: Karaya, Kazuhiro, et al.
Publicado: (2005)

CCAAT/Enhancer Binding Protein β Is Dispensable for Development of Lung Adenocarcinoma
por: Cai, Yi, et al.
Publicado: (2015)

Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy
por: Blute, Michael L., et al.
Publicado: (2017)

CCAAT/enhancer binding protein β is required for satellite cell self-renewal
por: Lala-Tabbert, Neena, et al.
Publicado: (2016)

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
por: Denmeade, Samuel R, et al.
Publicado: (2023)

Loss of IKKβ but Not NF-κB p65 Skews Differentiation towards Myeloid over Erythroid Commitment and Increases Myeloid Progenitor Self-Renewal and Functional Long-Term Hematopoietic Stem Cells
por: Zhang, Jing, et al.
Publicado: (2015)

CCAAT/Enhancer Binding Protein β in relation to ER Stress, Inflammation, and Metabolic Disturbances
por: van der Krieken, Sophie E., et al.
Publicado: (2015)

CCAAT/Enhancer Binding Protein β inhibits myogenic differentiation via ID3
por: AlSudais, Hamood, et al.
Publicado: (2018)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

CCAAT/Enhancer Binding Protein β Regulates Expression of Indian Hedgehog during Chondrocytes Differentiation
por: Ushijima, Takahiro, et al.
Publicado: (2014)

CCAAT-Enhancer Binding Protein-β Expression and Elevation in Alzheimer’s Disease and Microglial Cell Cultures
por: Strohmeyer, Ron, et al.
Publicado: (2014)

Contaminating reactivity of a monoclonal CCAAT/Enhancer Binding Protein β antibody in differentiating myoblasts
por: AlSudais, Hamood, et al.
Publicado: (2019)

Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein β
por: Darvishi, Emad, et al.
Publicado: (2022)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas
por: Fang, Tao, et al.
Publicado: (2015)

CCAAT/enhancer binding proteins in normal mammary development and breast cancer
por: Zahnow, Cynthia A
Publicado: (2002)

Biological roles of CCAAT/Enhancer-binding protein delta during inflammation
por: Ko, Chiung-Yuan, et al.
Publicado: (2015)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
por: Fujimoto, Naohiro, et al.
Publicado: (2011)

Reply: Prostate cancer, insulin and androgen deprivation therapy
por: Lehrer, S
Publicado: (2003)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

Androgen deprivation therapy in high risk prostate cancer
por: Van Dams, Ritchell, et al.
Publicado: (2019)

Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
por: Corona, Giovanni, et al.
Publicado: (2021)

Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cells
por: Barakat, David J., et al.
Publicado: (2018)

Cyclic AMP Responsive Element Binding Proteins Are Involved in ‘Emergency’ Granulopoiesis through the Upregulation of CCAAT/Enhancer Binding Protein β
por: Hirai, Hideyo, et al.
Publicado: (2013)

Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
por: Hussain, Arif, et al.
Publicado: (2020)

Impact of Androgen Deprivation on Oxidative Stress and Antioxidant Status in Nigerian Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
por: Bassey, Iya Eze, et al.
Publicado: (2020)

S-nitrosoglutathione inhibits adipogenesis in 3T3-L1 preadipocytes by S-nitrosation of CCAAT/enhancer-binding protein β
por: Mussbacher, Marion, et al.
Publicado: (2019)

SAT-333 CCAAT Enhancer Binding Protein Β(C/EBPΒ)-induced Axl in Early Breast Cancer Progression
por: Burke, Caitlin, et al.
Publicado: (2019)

Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer
por: Ishizaki, Fumio, et al.
Publicado: (2013)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
por: Hwang, Justin H., et al.
Publicado: (2019)

Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein δ
por: Yamaguchi, Junna, et al.
Publicado: (2015)

The CCAAT/Enhancer-Binding Protein Family: Its Roles in MDSC Expansion and Function
por: Wang, Wenxin, et al.
Publicado: (2019)

CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding
por: Wang, Lexun, et al.
Publicado: (2022)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Role of the CCAAT-Binding Protein NFY in SCA17 Pathogenesis
por: Lee, Li-Ching, et al.
Publicado: (2012)

The CCAAT-binding complex coordinates the oxidative stress response in eukaryotes
por: Thön, Marcel, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_et2qas8s83nb89pdrj61nn7kk2